Adactar, Yuhan D.
HRN: 21-54-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2023
CEFUROXIME 750MG (VIAL)
09/28/2023
10/05/2023
IV
270mg
Q8H
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes